Skip to content

Other expenses at other companies

Travel + Leisure logo
Travel + LeisureTNL
$5M+150%
Dave, Inc. logo
Dave, Inc.DAVE
$98.85M+35.7%
PennyMac Financial Services, Inc. logo
PennyMac Financial Services, Inc.PFSI
$440.29M+34.8%
Consensus Cloud Solutions, Inc. logo
Consensus Cloud Solutions, Inc.CCSI
$33.83M+7.1%
MetroCity Bankshares logo
MetroCity BanksharesMCBS
$4.92M+58.0%
Atmus Filtration Technologies logo
Atmus Filtration TechnologiesATMU
-$6.1M-3,150%

Other financials

Income statement

See full
Revenue$1.7M
Gross profit$1.3M
Operating income-$28.6M-283%
Net income-$26.6M-244%
EPS (diluted)-$0.27-145%

Balance sheet

See full
Cash & equivalents$2.6M+2,350,466%
Total equity$35.3M-1.0%
Total assets$100.7M+10.1%

Cash flow

See full
Operating cash flow-$3.8M-179%

Valuation

See full
Market cap$60.45M-74.7%

Returns & leverage

See full
Return on equity-119.9%+46.7pp
Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherExpenses.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s other expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Citius Oncology, Inc.'s other expenses?
Citius Oncology, Inc. (CTOR) reported other expenses of $27.94K in Q1 2026.
How has Citius Oncology, Inc.'s other expenses changed year-over-year?
Citius Oncology, Inc.'s other expenses decreased by 8.0% year-over-year, from $30.37K to $27.94K.
What is the long-term trend for Citius Oncology, Inc.'s other expenses?
Over 2 years (2023 to 2025), Citius Oncology, Inc.'s other expenses has grown at a -2.0% compound annual growth rate (CAGR), from $121.47K to $116.61K.